Table 1. Clinical and pathological characteristics of the included patients at baseline.
Characteristic | Patients (n=21) |
---|---|
Age (years), median [range] | 48 [28–57] |
Clinical tumor stage, n (%) | |
T1 | 2 (9.5) |
T2 | 6 (28.6) |
T3 | 2 (9.5) |
T4 | 11 (52.4) |
Clinical lymph node status, n (%) | |
N0 | 2 (9.5) |
N1 | 6 (28.6) |
N2 | 8 (38.1) |
N3 | 5 (23.8) |
Clinical stage, n (%) | |
II | 4 (19.0) |
III | 17 (81.0) |
ECOG performance status, n (%) | |
0 | 21 (100.0) |
1 | 0 |
Histological type, n (%) | |
Invasive ductal carcinoma | 20 (95.2) |
Paget’s disease | 1 (4.8) |
Hormone receptor status, n (%) | |
ER and/or PgR positive | 8 (38.1) |
ER and PgR negative | 13 (61.9) |
Ki-67 level, n (%) | |
<30% | 5 (23.8) |
≥30% | 15 (71.4) |
Unknown | 1 (4.8) |
ER, estrogen receptor; PgR, progestogen receptor.